United Kingdom · Question · Written question
UIN 56598
Restless Legs Syndrome: Medical Treatments
Original
Introduced
2 June 2025
Last action
5 June 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
5 June 2025
Summary
To ask the Secretary of State for Health and Social Care, what assessment he made of the use of dopamine agonists as a first-line treatment for restless legs syndrome (RLS) before the NICE guidance was updated in February 2025; and what steps he is taking
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 June 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment he made of the use of dopamine agonists as a first-line treatment for restless legs syndrome (RLS) before the NICE guidance was updated in February 2025; and what steps he is taking
Source: Commons
5 June 2025
Answer
No assessment has been made. The National Institute for Health and Care Excellence has not developed any guidelines on the diagnosis and/or management of restless leg syndrome (RLS) but has commissioned a Clinical Knowledge Summary (CKS) on the diagnosis ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-06-02/56598
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1808329
- uk · wq-1808329 · source updated 5 June 2025